Table 1.
Statistically significant comparisons in demographics, main COVID-19 related symptoms, medications and comorbidities between patients with asymptomatic, mild or moderate disease and those with severe or critical disease.
| Patients with asymptomatic, mild or moderate disease (n = 67) | Patients with severe or critical disease (n = 10) | p-value | |
|---|---|---|---|
| Demographics | |||
| Age (mean ± SD, years) | 46.6 ± 15.4 | 68.9 ± 12.8 | <0.001 |
| COVID-19 symptoms | |||
| Fever low grade (%) | 50.7 | 10.0 | 0.016 |
| Fever high grade (%) | 25.4 | 70.0 | 0.008 |
| Headache (%) | 29.0 | 0.0 | 0.045 |
| Shortness of breath (%) | 9.0 | 50.0 | <0.001 |
| Seizures (%) | 0.0 | 10.0 | 0.009 |
| Medications | |||
| Methylprednisolone (%) | 29.9 | 60.0 | 0.003 |
| Azathioprine or Mycophenolate mofetil (%) | 17.9 | 40.0 | 0.005 |
| Mycophenolate mofetil (%) | 7.5 | 40.0 | 0.003 |
| Rituximab (%) | 0.0 | 10.0 | 0.009 |
| Comorbidities | |||
| Lung disease (%) | 9.0 | 50.0 | <0.001 |